Diabetes duration and advancing age independently predict diabetes complications

Duration of diabetes and advancing age independently predict diabetes complications, risk of death – The duration of diabetes and advancing age independently predict diabetes severity and risk of death in older adults with type 2 diabetes. In a new study led by Kaiser Permanente and the University of Chicago, researchers investigated contemporary rates of diabetes complications and risk of death then contrasted them across categories of age and duration of diabetes.

Pazopanib better than sunitinib in advanced kidney cancer

Pazopanib shows better quality-of-life in advanced kidney cancer – Two oral targeted drugs — Pazopanib (Votrient) and sunitinib (Sutent) — approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, the safety profile and many measures of quality of life favored pazopanib.

Urine test can diagnose and predict kidney transplant rejection

Urine test can diagnose, predict kidney transplant rejection — NIH-funded study describes noninvasive alternative to kidney biopsy – Analysis of three biomarkers in the urine of kidney transplant recipients can diagnose — and even predict — transplant rejection, according to results from a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Prevent colon cancer with colon cancer awareness

Work with your health care provider to find out what your personal risk is and how often you should be screened. Have you had your colon cancer screening test? – March is National Colorectal Cancer Awareness Month in US. “Colon cancer can be prevented with screening and removal of any polyps before they develop into cancer” says Sheryl M. Ness, R.N., Mayo Clinic nurse educator.

Anemia drug Omontys recalled due to anaphylaxis

US FDA alerts health care providers of recall of anemia drug Omontys – In US, Omontys Injection is recalled due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys.

Nutrition Facts Label helps to make heart healthy choices

The Nutrition Facts Label: Helping Americans Make Heart-Healthy Choices – February is American Heart Month, and the U.S. Food and Drug Administration has a tool to help you achieve a heart-healthy lifestyle. It?s called the Nutrition Facts Label, and it can be found on all packaged foods and beverages.

3 new drugs approved for type 2 diabetes in US

US FDA approves three new drug treatments for type 2 diabetes – Nesina, Kazano, and Oseni – The U.S. Food and Drug Administration approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.

Preventing kidney disease in diabetes may prolong life

Kidney disease accounts for most of the increased risk of dying early among diabetics — Preventing and treating kidney disease in those with diabetes could save lives – One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. That means almost 3 percent of Americans suffer from chronic kidney disease.

Sirturo – first drug to treat multi drug resistant tuberculosis

FDA approves first drug to treat multi-drug resistant tuberculosis – The U.S. Food and Drug Administration approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available.

Health Newstrack